Press release Communiqué de presse

Share the news     Partagez les nouvelles

Email Facebook LinkedIn Twitter

Press release Communiqué de presse


September 1, 2004 1 September, 2004

Asset Sale of Fertility Monitor Closes; HealthWatchSystems, Inc. Now Owns Product Outright


Toronto, Ontario (September 1, 2004) -- Pheromone Sciences Corp. (TSX:PHS), a Toronto based biotech R & D company announces the completion of all the requirements to close the sale of its Fertility Monitor technology to HealthWatchSystems, Inc, a Sarasota, Florida based health care company.

As part of the transaction, HealthWatchSystems, Inc. has acquired the patents related to this technology. Pheromone has received $400,000. and will receive a graduated royalty on world wide sales of the fertility monitor and any related products stemming from this technology until the earlier of the expiration of the patents or 2014.

"The completion of this agreement represents a significant milestone for Pheromone Sciences, while contributing to the healthcare needs of couples seeking help in conception" stated Christopher Neuman, President and CEO of Pheromone.

Pheromone Sciences Corp. is a biotechnology research and development company seeking new opportunities to leverage its resources.

Statements contained in this press release, including those pertaining to scientific and clinical research, commercialization plans, strategic alliances, and intellectual property protection, other than statements of historical fact, are forward-looking statements subject to a number of uncertainties that could cause actual results to differ materially from statements made. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or the contents of this news release.